ID   AL1A2_HUMAN             Reviewed;         518 AA.
AC   O94788; B3KY52; B4DZR2; F5H2Y9; H0YM00; Q2PJS6; Q8NHQ4; Q9UBR8;
AC   Q9UFY0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=Retinal dehydrogenase 2;
DE            Short=RALDH 2;
DE            Short=RalDH2;
DE            EC=1.2.1.36;
DE   AltName: Full=Aldehyde dehydrogenase family 1 member A2;
DE   AltName: Full=Retinaldehyde-specific dehydrogenase type 2;
DE            Short=RALDH(II);
GN   Name=ALDH1A2; Synonyms=RALDH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), AND VARIANT ILE-348.
RX   PubMed=9819382; DOI=10.1128/MCB.18.12.6939;
RA   Ono Y., Fukuhara N., Yoshie O.;
RT   "TAL1 and LIM-only proteins synergistically induce retinaldehyde
RT   dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by
RT   acting as cofactors for GATA3.";
RL   Mol. Cell. Biol. 18:6939-6950(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   ILE-348.
RC   TISSUE=Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-50; VAL-110;
RP   ILE-348 AND LYS-436.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 302-518 (ISOFORMS 1/2), AND
RP   VARIANT ILE-348.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-168 AND SER-351, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Recognizes as substrates free retinal and cellular
CC       retinol-binding protein-bound retinal. Does metabolize octanal and
CC       decanal but does not metabolize citral, benzaldehyde, acetaldehyde
CC       and propanal efficiently (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Retinal + NAD(+) + H(2)O = retinoate + NADH.
CC   -!- PATHWAY: Cofactor metabolism; retinol metabolism.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O94788-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O94788-2; Sequence=VSP_017363;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O94788-3; Sequence=VSP_044496;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O94788-4; Sequence=VSP_047259;
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/aldh1a2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB015226; BAA34785.1; -; mRNA.
DR   EMBL; AB015227; BAA34786.1; -; mRNA.
DR   EMBL; AB015228; BAA34787.1; -; mRNA.
DR   EMBL; AK128709; BAG54714.1; -; mRNA.
DR   EMBL; AK303057; BAG64174.1; -; mRNA.
DR   EMBL; DQ322171; ABC40749.1; -; Genomic_DNA.
DR   EMBL; AC012653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC018904; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC066616; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030589; AAH30589.1; -; mRNA.
DR   EMBL; AL110299; CAB53740.2; -; mRNA.
DR   CCDS; CCDS10163.1; -. [O94788-1]
DR   CCDS; CCDS10164.1; -. [O94788-2]
DR   CCDS; CCDS45266.1; -. [O94788-4]
DR   CCDS; CCDS55968.1; -. [O94788-3]
DR   PIR; T14799; T14799.
DR   RefSeq; NP_001193826.1; NM_001206897.1. [O94788-3]
DR   RefSeq; NP_003879.2; NM_003888.3. [O94788-1]
DR   RefSeq; NP_733797.1; NM_170696.2. [O94788-2]
DR   RefSeq; NP_733798.1; NM_170697.2. [O94788-4]
DR   UniGene; Hs.643455; -.
DR   PDB; 4X2Q; X-ray; 2.94 A; A/B/C/D=21-518.
DR   PDBsum; 4X2Q; -.
DR   ProteinModelPortal; O94788; -.
DR   SMR; O94788; -.
DR   BioGrid; 114379; 4.
DR   IntAct; O94788; 2.
DR   STRING; 9606.ENSP00000249750; -.
DR   BindingDB; O94788; -.
DR   ChEMBL; CHEMBL3112384; -.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00755; Tretinoin.
DR   DrugBank; DB00162; Vitamin A.
DR   iPTMnet; O94788; -.
DR   PhosphoSitePlus; O94788; -.
DR   BioMuta; ALDH1A2; -.
DR   EPD; O94788; -.
DR   MaxQB; O94788; -.
DR   PaxDb; O94788; -.
DR   PeptideAtlas; O94788; -.
DR   PRIDE; O94788; -.
DR   DNASU; 8854; -.
DR   Ensembl; ENST00000249750; ENSP00000249750; ENSG00000128918. [O94788-1]
DR   Ensembl; ENST00000347587; ENSP00000309623; ENSG00000128918. [O94788-2]
DR   Ensembl; ENST00000537372; ENSP00000438296; ENSG00000128918. [O94788-3]
DR   Ensembl; ENST00000559517; ENSP00000453408; ENSG00000128918. [O94788-4]
DR   GeneID; 8854; -.
DR   KEGG; hsa:8854; -.
DR   UCSC; uc002aew.4; human. [O94788-1]
DR   CTD; 8854; -.
DR   DisGeNET; 8854; -.
DR   GeneCards; ALDH1A2; -.
DR   H-InvDB; HIX0038341; -.
DR   HGNC; HGNC:15472; ALDH1A2.
DR   HPA; HPA010022; -.
DR   MIM; 603687; gene.
DR   neXtProt; NX_O94788; -.
DR   OpenTargets; ENSG00000128918; -.
DR   PharmGKB; PA24693; -.
DR   eggNOG; KOG2450; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   GeneTree; ENSGT00760000118999; -.
DR   HOGENOM; HOG000271505; -.
DR   HOVERGEN; HBG000097; -.
DR   InParanoid; O94788; -.
DR   KO; K07249; -.
DR   OMA; KPIANAY; -.
DR   OrthoDB; EOG091G05E8; -.
DR   PhylomeDB; O94788; -.
DR   TreeFam; TF300455; -.
DR   BioCyc; MetaCyc:HS05232-MONOMER; -.
DR   Reactome; R-HSA-5365859; RA biosynthesis pathway.
DR   UniPathway; UPA00912; -.
DR   ChiTaRS; ALDH1A2; human.
DR   GeneWiki; ALDH1A2; -.
DR   GenomeRNAi; 8854; -.
DR   PRO; PR:O94788; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000128918; -.
DR   CleanEx; HS_ALDH1A2; -.
DR   ExpressionAtlas; O94788; baseline and differential.
DR   Genevisible; O94788; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IBA:GO_Central.
DR   GO; GO:0016918; F:retinal binding; ISS:UniProtKB.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0042904; P:9-cis-retinoic acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0009855; P:determination of bilateral symmetry; IEA:Ensembl.
DR   GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
DR   GO; GO:0048566; P:embryonic digestive tract development; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0060324; P:face development; IEA:Ensembl.
DR   GO; GO:0003007; P:heart morphogenesis; IEA:Ensembl.
DR   GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0007494; P:midgut development; IEA:Ensembl.
DR   GO; GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0014032; P:neural crest cell development; IEA:Ensembl.
DR   GO; GO:0021915; P:neural tube development; IMP:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0001936; P:regulation of endothelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0034097; P:response to cytokine; IDA:UniProtKB.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0042574; P:retinal metabolic process; IEA:Ensembl.
DR   GO; GO:0042573; P:retinoic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0035799; P:ureter maturation; IEA:Ensembl.
DR   GO; GO:0006776; P:vitamin A metabolic process; NAS:UniProtKB.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm; NAD;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    518       Retinal dehydrogenase 2.
FT                                /FTId=PRO_0000056422.
FT   NP_BIND     263    268       NAD. {ECO:0000250}.
FT   ACT_SITE    286    286       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008}.
FT   ACT_SITE    320    320       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008}.
FT   SITE        187    187       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES     168    168       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     351    351       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     96       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9819382}.
FT                                /FTId=VSP_047259.
FT   VAR_SEQ       1     39       MTSSKIEMPGEVKADPAALMASLHLLPSPTPNLEIKYTK
FT                                -> MKNQCETVWLKSPIKLKL (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044496.
FT   VAR_SEQ     229    266       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017363.
FT   VARIANT      50     50       E -> G (in dbSNP:rs34266719).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025439.
FT   VARIANT     110    110       A -> V (in dbSNP:rs35365164).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025440.
FT   VARIANT     348    348       V -> I (in dbSNP:rs4646626).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:9819382,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025441.
FT   VARIANT     436    436       E -> K (in dbSNP:rs34744827).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025442.
FT   CONFLICT    231    231       F -> L (in Ref. 2; BAG64174).
FT                                {ECO:0000305}.
FT   STRAND       39     42       {ECO:0000244|PDB:4X2Q}.
FT   STRAND       45     47       {ECO:0000244|PDB:4X2Q}.
FT   STRAND       54     58       {ECO:0000244|PDB:4X2Q}.
FT   TURN         60     62       {ECO:0000244|PDB:4X2Q}.
FT   STRAND       65     70       {ECO:0000244|PDB:4X2Q}.
FT   HELIX        74     86       {ECO:0000244|PDB:4X2Q}.
FT   HELIX        93     96       {ECO:0000244|PDB:4X2Q}.
FT   HELIX        99    115       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       117    128       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       132    137       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       139    153       {ECO:0000244|PDB:4X2Q}.
FT   TURN        154    156       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      165    176       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      178    183       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      186    188       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       189    202       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      206    210       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       217    229       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      235    238       {ECO:0000244|PDB:4X2Q}.
FT   TURN        243    245       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       246    251       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      257    263       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       265    273       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      282    286       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      293    295       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       301    309       {ECO:0000244|PDB:4X2Q}.
FT   TURN        310    312       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       314    317       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      324    329       {ECO:0000244|PDB:4X2Q}.
FT   TURN        330    332       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       333    344       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       365    379       {ECO:0000244|PDB:4X2Q}.
FT   TURN        380    382       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      384    387       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      394    396       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      402    407       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       412    415       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      420    428       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       431    439       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      446    450       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       454    463       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      467    472       {ECO:0000244|PDB:4X2Q}.
FT   TURN        497    499       {ECO:0000244|PDB:4X2Q}.
FT   HELIX       500    503       {ECO:0000244|PDB:4X2Q}.
FT   STRAND      504    512       {ECO:0000244|PDB:4X2Q}.
SQ   SEQUENCE   518 AA;  56724 MW;  AAEE7A886951373F CRC64;
     MTSSKIEMPG EVKADPAALM ASLHLLPSPT PNLEIKYTKI FINNEWQNSE SGRVFPVYNP
     ATGEQVCEVQ EADKADIDKA VQAARLAFSL GSVWRRMDAS ERGRLLDKLA DLVERDRAVL
     ATMESLNGGK PFLQAFYVDL QGVIKTFRYY AGWADKIHGM TIPVDGDYFT FTRHEPIGVC
     GQIIPWNFPL LMFAWKIAPA LCCGNTVVIK PAEQTPLSAL YMGALIKEAG FPPGVINILP
     GYGPTAGAAI ASHIGIDKIA FTGSTEVGKL IQEAAGRSNL KRVTLELGGK SPNIIFADAD
     LDYAVEQAHQ GVFFNQGQCC TAGSRIFVEE SIYEEFVRRS VERAKRRVVG SPFDPTTEQG
     PQIDKKQYNK ILELIQSGVA EGAKLECGGK GLGRKGFFIE PTVFSNVTDD MRIAKEEIFG
     PVQEILRFKT MDEVIERANN SDFGLVAAVF TNDINKALTV SSAMQAGTVW INCYNALNAQ
     SPFGGFKMSG NGREMGEFGL REYSEVKTVT VKIPQKNS
//
